Study Looks at Use of TMS to Treat Depression

The Carlat Psychiatry Report, Volume 10, Number 9, September 2012

Glen Spielmans, PhD

Associate professor of psychology, Metropolitan State University, St. Paul, MN

Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Transcranial magnetic stimulation, or TMS, was approved by the FDA for treatment of major depression in October 2008. A newly published observational study evaluating the effectiveness of TMS treatment in more than 300 patients at 42 clinical settings across the United States has found that most patients responded well to this intervention, with few adverse effects (Carpenter LL et al, Dep Anx 2012;29(8):587–596).

You can't view details of this content, please login or buy subscription here